Dan Lu,Si Chen,Xiaoyue Tan,Na Li,Chenghu Liu,Zongjin Li,Ze Liu,Dwayne G. Stupack,Ralph A. Reisfeld,Rong Xiang

Abstract:<p>PDF file - 159K, Cell proliferation was evaluated by cell cycle analysis. Cell cycle profiles of 4TO7 cells with Fra-1 extinction (A) and ectopic expression (B) were confirmed by FACS. Cells were fixed by 70% ethanol, incubated in PBS buffer with RNase A and then stained with propidium iodide (PI) overnight. Data were collected on the following day</p>

Supplementary Figure 3 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 5 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 2 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 4 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 6 from HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells

Supplementary Figure 2 from &Lt;i>fra-1&Lt;/i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure Legends 1-4 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 2 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

Supplementary Figure 3 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 5 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 3 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 1 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 4 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 1 from <i>Fra-1</i> Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy

Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure 7 from CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer

Supplementary Figure 1 from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure Legend from Smac Mimetics in Combination with TRAIL Selectively Target Cancer Stem Cells in Nasopharyngeal Carcinoma